M.A. Gassull
About
In The Last Decade
M.A. Gassull
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Nutrition and Dietetics 452
- Physiology 384
- Genetics 307
- Surgery 262
- Epidemiology 195
Countries citing papers authored by M.A. Gassull
This map shows the geographic impact of M.A. Gassull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Gassull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Gassull more than expected).
Fields of papers citing papers by M.A. Gassull
This network shows the impact of papers produced by M.A. Gassull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Gassull. The network helps show where M.A. Gassull may publish in the future.
Co-authorship network of co-authors of M.A. Gassull
This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Gassull. A scholar is included among the top collaborators of M.A. Gassull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Gassull. M.A. Gassull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. | 107 |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 5 | |
| 15 | Vitamin status in patients with inflammatory bowel disease. | 164 |
| 16 | 131 | |
| 17 | 330 | |
| 18 | 3 | |
| 19 | 201 | |
| 20 | 22 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.